Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Interesting. Just listened. Thanks.
Did you happen to listen to the post I make on Trish Lackey- Director of Marketing at Sunday market . It's a good listen..
https://www.reddit.com/r/aleafia/comments/qqc783/how_to_build_a_cannabis_brand_in_a_highly/?utm_medium=android_app&utm_source=share
I feel as if I am at sea helplessly watching a storm coming in, wondering if anyone at the helm knows what they are doing.
Hey all. It's been a while. Are we ready for what's to come.
The biggest outdoor harvest yet should be coming in and drying.
With no other growth plans, they have to show expanding margins and less reliance on wholesale.
That means increasing their branded product sales.
Otherwise they are toast and the money I invested is going up in smoke.
Many people, including myself, had high expectations for this company. It's not over yet, but it is indeed "show me" time.
Agreed. Show me.
Rest hope we get some positive news. I’d this doesn’t happen this stock might be done
Aleafia Health to Announce 2021 Third Quarter Results
Nov. 03, 2021 11:00 AM ET
Aleafia Health Inc. (ALEAF)
https://seekingalpha.com/pr/18542906-aleafia-health-to-announce-2021-third-quarter-results?fbclid=IwAR2f_NvJBVBprNeVfbmT1dfVbX--nVw_0WxE_cCWXFok9U7MFvBQrjYQQrk
TORONTO, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (ALEAF) (“Aleafia Health” or the “Company”) will announce its 2021 third quarter results on November 11, 2021 prior to market open. The Company will also host its earnings conference call the same day at 9:30 a.m. ET. The call will be hosted by CEO Geoffrey Benic and CFO Matt Sale.
CONFERENCE CALL & WEBCAST
Date: November 11, 2021
Time: 9:30 a.m. ET
USA/Canada Toll-Free Participant Call-in: (866) 679-9046; Passcode: 5588397
International Toll-Free Participant Call-in: (409) 217-8323; Passcode: 5588397
WEBCAST LINK
This conference call will be webcast live over the internet and can be accessed through the link provided. Audio of the call will be available to participants through both the conference call line and webcast; however, the presentation may only be viewed via the webcast. Participants who miss the live call can view a replay at any time via the link provided.
For Investor & Media Relations:
Nicholas Bergamini, VP Investor Relations
1-833-879-2533
IR@AleafiaHealth.com
LEARN MORE: www.AleafiaHealth.com
About Aleafia Health:
Aleafia Health is a vertically integrated and federally licensed Canadian cannabis company offering cannabis health and wellness services and products in Canada and with sales and operations in Australia and Germany. The Company operates medical clinics, education centres and production facilities for the production and sale of cannabis.
Aleafia Health owns four significant licensed cannabis production facilities, including the first large-scale, legal outdoor cultivation facility in Canadian history. The Company produces a diverse portfolio of commercially proven, high-margin derivative products including oils, capsules, edibles, sublingual strips, and vapes. Aleafia Health operates the largest national network of medical cannabis clinics and education centres staffed by MDs, nurse practitioners and educators and operates internationally in three continents.
Forward Looking Information
This news release contains forward-looking information within the meaning of applicable Canadian and United States securities laws. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, or “believes” or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company or its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including risks contained in the Company’s annual information form filed with Canadian securities regulators available on the Company’s SEDAR profile at www.sedar.com. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company does not undertake any obligation to publicly update such forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.
Cantech Letter
Search Search
All
Software
Cannabis
Fintech
Life Sciences
Security
Cleantech
Analysts
By Geordie Carragher September 30, 2021 Filed under: All posts, Analysts, Cannabis Stock: ah
Aleafia Health’s market share to grow, Research Capital says
Research Capital Corporation analyst Venkata Velagapudi is all about Aleafia Health (Aleafia Health Stock Quote, Chart, News, Analysts, Financials TSX:AH), initiating coverage on the company with a “Buy” rating and target price of $0.75/share to imply a projected return of 111 per cent in an update to clients on September 20.
Founded in 2007 and headquartered in Concord, Ont., Aleafia Health is an integrated cannabis health and wellness services company with a diverse portfolio of products, including dried flower and pre-rolls, oil drops and capsules, oral sprays and cannabis-infused sublingual strips. The company operates a network of 25 Canabo medical marijuana clinics and it sells products under multiple labels.
“We believe that Aleafia’s revenue growth will be mainly driven by its adult-use cannabis segment, which has a large addressable market for LPs in Canada,” Velagapudi said of the company’s future projections. “We estimate the addressable market for LPs to reach $5.1 billion by 2025.”
Velagapudi also believes the company is set to increase its Canadian market share to two per cent from its current 0.6 per cent hold, with Velagapudi noting that the estimates area driven by Aleafia’s recent launch of value brands, the ability to manufacture cannabis derivatives to create value through its low cost structure, long-term expansion of its distribution network and an expectation that the company will allocate a higher quantity of raw material to its adult-use cannabis segment instead of providing cultivation and extraction services to other licensed producers.
Since achieving its first cannabis revenue in 2018, Aleafia has been busy across the board, investing in Australian operator CannaPacific and gaining an export license in Australia in July 2019, shortly after merging with Emblem, which is one of the labels Aleafia sells.
From there, the company made inroads into the German market through a joint venture with Acnos Pharma in May 2019, completing its cannabis export in June 2021. Aleafia, through the Emblem brand, completed an EU-GMP application in May 2020, and also has made strides in the Israeli market through a letter of intent with Equinox in December 2020.
Most recently, the company launched two premium cannabis brands, Nith and Grand, in August.
Meanwhile, Aleafia has also entered into a ten-year agreement with Unifor, Canada’s largest private sector union, to provide medical cannabis insurance coverage through collective bargaining agreements, potentially representing a $315 million opportunity.
The company’s most recent quarterly financial report was headlined by $9.6 million in cannabis net revenue for sequential growth of 53 per cent, which the company attributed to increases in the sale of cannabis across the adult-use, medical and bulk wholesale sales channels, with each sales channel providing near equal contributions ($3.3 million in net medical cannabis revenue, $3.2 million in net adult-use cannabis, and $3.1 million in net bulk wholesale revenue received from sales to cannabis licensed producers).
“This quarter clearly demonstrates the success of our expanded product portfolio, with strong sequential growth across all sales channels and a shift towards a more balanced mix with sizable contributions from both the medical and adult-use cannabis markets. Credit goes to our management team and employees for delivering record adult-use, and medical cannabis revenue this quarter,” said Aleafia Health CEO Geoffrey Benic in the company’s August 12 press release. “Despite industry-wide price compression, we have maintained robust gross margins on cannabis revenue when compared to other Canadian licensed producers, based on most recently reported quarterly results. This was achieved through our twin pillars of low-cost cultivation and high-quality, differentiated cannabis derivative formats.”
After reporting $45 million in revenue in 2020, Velagapudi projects a slight dip to $41 million for 2021, followed by a near 50 per cent potential year-over-year increase to $61 million in 2022, with another 50 per cent jump to a projected $93 million in the works for 2023. The company’s gross margin is expected to dip in that timeframe, falling from 53 per cent in 2020 to a projected 43 per cent in 2021, then to 41 per cent in 2022 before settling in at a projected 40 per cent in 2023.
Meanwhile, Velagapudi projects the company’s EBITDA to turn positive in 2023 at a projected $1 million following projected losses of $14 million and $16 million in 2021 and 2022, respectively.
Velagapudi believes the company will need to reach a revenue base between $25 and $30 million to generate positive operating cash flow, with an expectation that the company will reach that benchmark by 2023.
“Consistent improvement in adult-use cannabis market share, maintaining strong gross margins along with expanding revenue base, and visibility over positive operating cash flow may be key for improving the valuation multiples for Aleafia,” Velagapudi said.
10/05/2021 07:02 AM ET
Aleafia Health Builds on Adult-use Momentum with Retailer Harvest Party
TORONTO, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) ("Aleafia Health" or the "Company") hosted a second annual adult-use retailer harvest party at its outdoor cultivation facility, with over 300 cannabis store owners, managers, budtenders and industry leaders attending. The two-day conference included retailer tours at the 86 acre outdoor site in Port Perry, Ont. and education sessions featuring the company's cultivation methods and proprietary cultivars that make up its growing cannabis product portfolio.
"It was a privilege to provide a behind the scenes look at our outdoor cultivation facility and see firsthand the strong engagement and relationships we are building with cannabis retailers in Canada's largest market. Month over month, we continue to increase our market share and develop a meaningful following for our Sunday Market brand family," said Aleafia Health CEO Geoffrey Benic.
The Company has realized another strong period of sequential growth in adult-use sales in the quarter ending September 30, 2021, following a 93% increase in adult-use net revenue during Q2 2021. The growth has been in part driven by its everyday cannabis brand Divvy, with several important additional listings secured in Ontario launching October, including:
-- Black Widow CBD 14g Dried Flower: Capitalizing on a gap in the product
landscape for large format CBD-dominant dried flower, black widow is a
terpene rich, indica-dominant cultivar and long-standing signature strain
for Aleafia Health's medical patients.
-- FLO 14g Dried Flower: Flo's high-potency and unique terpene profile makes
it a highly sought-after cultivar now available for the first time in the
Ontario market, following a successful Alberta launch.
Part of the Sunday Market brand family which features five distinct brands with differentiated products tailored to specific consumer segments, Divvy leverages Aleafia Health's core competitive advantage of low-cost cultivation both at its Niagara Greenhouse and Port Perry outdoor cultivation facility. Also poised for a successful outdoor cultivation harvest, the Company completed planting at the 86-acre site over a month earlier than in 2020.
For Investor & Media Relations:
Nicholas Bergamini, VP Investor Relations
1-833-879-2533
IR@AleafiaHealth.com
LEARN MORE: www.AleafiaHealth.com
About Aleafia Health:
Aleafia Health is a vertically integrated and federally licensed Canadian cannabis company offering cannabis health and wellness services and products in Canada. The Company has developed an international footprint, with subsidiaries or investments in German and Australian medical cannabis companies and has products available in both markets. The Company owns and operates a virtual network of medical cannabis clinics staffed by physicians and nurse practitioners who have seen over 75,000 patients to date.
Aleafia Health owns three licensed cannabis production facilities and operates a strategically located distribution centre all in the province of Ontario, including the first large-scale, legal outdoor cultivation facility in Canadian history. The Company produces a diverse portfolio of cannabis derivative products including oils, capsules, edibles, sublingual strips, and vapes, for sale in Canada in the medical and adult-use markets, and in select international jurisdictions.
I have not heard. That is a great question
When is the harvest due? It’s already getting cold in Canada and they are still haven’t announced anything. Behind again?
I hope so too. Small stocks like this have to be watched closely. I take comfort that so far they have done what they say they are going to do
The outdoor harvest should be about 4x's the size as last year's.
They brag about selling a lot of wholesale, so let's see if the wholesale is profitable.
We'll also be keenly looking to see if their own own branded products are generating consumer demand.
I just hope that management doesn’t eat the numbers for their advantage.
It will as soon as there is uptake from the union members on the medical side and the divy proves it is good quality. They are very well positioned they just need to be recognized. Everybody knows canopy and the other names that are in such trouble now, it is hard to get out from under that cloud. When Aleafia starts putting in good numbers folks will start to notice.
Decent news FUN. We'll see if it builds a little fire under this one.
Aleafia Health Builds on Adult-use Momentum with Retailer Harvest Party
Aleafia Health Inc.
Tue, October 5, 2021, 7:00 AM·4 min read
https://finance.yahoo.com/news/aleafia-health-builds-adult-momentum-110000917.html
TORONTO, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) hosted a second annual adult-use retailer harvest party at its outdoor cultivation facility, with over 300 cannabis store owners, managers, budtenders and industry leaders attending. The two-day conference included retailer tours at the 86 acre outdoor site in Port Perry, Ont. and education sessions featuring the company’s cultivation methods and proprietary cultivars that make up its growing cannabis product portfolio.
“It was a privilege to provide a behind the scenes look at our outdoor cultivation facility and see firsthand the strong engagement and relationships we are building with cannabis retailers in Canada’s largest market. Month over month, we continue to increase our market share and develop a meaningful following for our Sunday Market brand family,” said Aleafia Health CEO Geoffrey Benic.
The Company has realized another strong period of sequential growth in adult-use sales in the quarter ending September 30, 2021, following a 93% increase in adult-use net revenue during Q2 2021. The growth has been in part driven by its everyday cannabis brand Divvy, with several important additional listings secured in Ontario launching October, including:
Black Widow CBD 14g Dried Flower: Capitalizing on a gap in the product landscape for large format CBD-dominant dried flower, black widow is a terpene rich, indica-dominant cultivar and long-standing signature strain for Aleafia Health’s medical patients.
FLO 14g Dried Flower: Flo’s high-potency and unique terpene profile makes it a highly sought-after cultivar now available for the first time in the Ontario market, following a successful Alberta launch.
Part of the Sunday Market brand family which features five distinct brands with differentiated products tailored to specific consumer segments, Divvy leverages Aleafia Health’s core competitive advantage of low-cost cultivation both at its Niagara Greenhouse and Port Perry outdoor cultivation facility. Also poised for a successful outdoor cultivation harvest, the Company completed planting at the 86-acre site over a month earlier than in 2020.
For Investor & Media Relations:
Nicholas Bergamini, VP Investor Relations
1-833-879-2533
IR@AleafiaHealth.com
LEARN MORE: www.AleafiaHealth.com
About Aleafia Health:
Aleafia Health is a vertically integrated and federally licensed Canadian cannabis company offering cannabis health and wellness services and products in Canada. The Company has developed an international footprint, with subsidiaries or investments in German and Australian medical cannabis companies and has products available in both markets. The Company owns and operates a virtual network of medical cannabis clinics staffed by physicians and nurse practitioners who have seen over 75,000 patients to date.
Aleafia Health owns three licensed cannabis production facilities and operates a strategically located distribution centre all in the province of Ontario, including the first large-scale, legal outdoor cultivation facility in Canadian history. The Company produces a diverse portfolio of cannabis derivative products including oils, capsules, edibles, sublingual strips, and vapes, for sale in Canada in the medical and adult-use markets, and in select international jurisdictions.
Forward Looking Information
This news release contains forward-looking information within the meaning of applicable Canadian and United States securities laws. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes” or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Specific forward-looking information contained in this release includes information relating, but not limited, to the Credit Facility, including the use of the net proceeds from the Credit Facility, and the Warrants. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company or its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including risks contained in the Company’s annual information form filed with Canadian securities regulators available on the Company’s SEDAR profile at www.sedar.com. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company does not undertake any obligation to publicly update such forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.
Is this company will ever move?
Divy, Sour Kush High thc (19-25%) $5.70 cdn per gram for 3.5 g it is $19.95 they have pre rolls too. I like this move
https://ocs.ca/products/sour-kush-divvy
I got a divy pin at my dispensary today :) They are actively promoting. Happy to see that
Did you listen to it? He gave an update. He was almost giddy talking about the outdoor operation, they have so much business at this time they are using contracted growers and Ford employees have just started being able to access their medicine. I would say that is a very good update. Nothing in this industry is going as quickly as we would like but progress is being made. Their Bogart’s salted caramels are delicious (I enjoy them regularly) there are more stores opening all the time. They are making good choices in every aspect they have control over. As far as the government and their policies, it is a work in progress.
Who gives a sh!t about his presentation. This is old story and no one cares. Give us updates! This is becoming very upsetting.
Still sidelined FUN but watching my friend.
Aleafia Health CEO Geoffrey Benic to Present at OTC Markets Virtual Investor Conference
Could they update harvest news?--->>> Cannabis Industry Investor Conference: Company Executives Present September 8th & 9th
Cannabis Company Executives share vision, answer questions live at VirtualInvestorConferences.com
NEWS PROVIDED BY
VirtualInvestorConferences.com
Sep 02, 2021, 08:35 ET
NEW YORK, Sept. 2, 2021 /PRNewswire/ -- Virtual Investor Conferences in partnership with KCSA Strategic Communications today announced the agenda for the upcoming Cannabis Industry Virtual lnvestor Conference. Individual investors, institutional investors, advisors and analysts are invited to attend. The two-day program begins at 11:30 AM ET on Wednesday, September 8th.
REGISTER NOW AT: https://bit.ly/2WFxX0e
It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates. There are no fees to log-in, attend the live presentations or ask questions.
Phil Carlson, Managing Director of KCSA Strategic Communications said, "Our 15th virtual conference with the OTC Markets has generated significant interest from both investors and cannabis companies to where we again have extended the conference to two days. We look forward to having some of the prominent global players in the cannabis industry present their story to the investment community."
September 8th Agenda:
Eastern
Time (ET)
Presenting Company
Ticker(s)
11:30 AM
Innocan Pharma Corp.
(OTCQX: INNPF| CSE: INNO)
12:00 PM
MariMed Inc.
(OTCQX: MRMD)
12:30 PM
The Valens Company Inc.
(OTCQX: VLNCF | TSX: VLNS)
1:00 PM
Nova Cannabis Inc.
(OTCQB: NVACF | TSX-V: NOVC)
1:30 PM
InMed Pharmaceuticals Inc.
(Nasdaq: INM)
2:00 PM
Vibe Growth Corp.
(Pink: VIBEF | CSE: VIBE)
2:30 PM
1933 Industries Inc.
OTCQB: TGIFF | CSE: TGIF
September 9th Agenda:
Eastern
Time (ET)
Presenting Company
Ticker(s)
10:00 AM
IM Cannabis Corp.
(NASDAQ: IMCC | CSE: IMCC)
10:30 AM
NewLake Capital Partners, Inc.
(OTCQX: NLCP)
11:00 AM
Aleafia Health Inc.
(OTCQX: ALEAF | TSX: AH)
11:30 AM
InterCure Ltd.
(NASDAQ: INCR | TSX: INCR.U)
12:00 PM
Verano Holdings Corp.
(OTCQX: VRNOF | CSE: VRNO)
12:30 PM
Fire & Flower Holdings Corp.
(OTCQX: FFLWF | TSX: FAF)
1:00 PM
SLANG Worldwide Inc.
(OTCQB: SLGWF | CSE: SLNG)
1:30 PM
Clever Leaves Holdings Inc.
(NASDAQ: CLVR, CLVRW)
2:00 PM
Australis Capital Inc.
(OTCQB: AUSAF | CSE: AUSA)
2:30 PM
Lowell Farms Inc.
(OTCQX: LOWLF | CSE: LOWL)
3:00 PM
Flower One Holdings Inc.
(OTCQX: FLOOF | CSE: FONE)
3:30 PM
Sugarbud Craft Growers Corp.
(OTCQB: SBUDF | TSX-V: SUGR)
4:00 PM
Greenrose Acquisition Corp.
(OTCQX: GNRS, GNRSU, GNRSW)
To facilitate investor relations scheduling, for more information about the program and to view a complete calendar of Virtual Investor Conferences, please visit www.virtualinvestorconferences.com.
About Virtual Investor ConferencesSM
Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly-traded companies to meet and present directly with investors.
A real-time solution for investor engagement, Virtual Investor Conferences is part of OTC Market Group's suite of investor relations services specifically designed for more efficient Investor Access. Replicating the look and feel of on-site investor conferences, Virtual Investor Conferences combine leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.
SOURCE VirtualInvestorConferences.com
You took the words outta my mouth FUN.
Aleafia Health Announces Appointment of David Pasieka to Board of Directors
"Happy", Aleafia is not only already supplying union member, but they are wholesaling "lower-margin" cannabis right now. That's BEFORE the outdoor harvest later this month/early October.
Aleafia just doesn't have the flow through relationships and "in-demand" brands.
Right now IMO their great asset will be their low production cost which should be a big revenue boost in Q4 when the outdoor harvest translates into wholesale revenue.
But then what? Those 86 acres won't be planted again until next April/May.
I am very down on Aleafia.
They're already supplying to the union patients so you are saying a larger influx of patients is coming and if so, that could be why the offering and what they are doing? You may be correct.
I haven't stopped watching it. It didn't seem to want to go below .20 or very close to it.
I think they are shoring up their supply line for when the Union deal starts generating patients (and revenues) they may have to buy from other growers to meet demand until they have a full idea of uptake. They saw all the “big guys” get saddled with redundant assets so I would rather see them buy wholesale for a bit and tweak their supply line as needed. Total guess here but that is what I would do in their place.
I'm on the sidelines FUN.
A 53% Increase in Cannabis Net Revenue on Aleafia Health (OTCMKTS: ALEAF)’s Q2 2021 Financial Results Demonstrates the Success of its Expanded Product Portfolio
By Neha Gupta
AUG 25, 2021
https://gentrybusinessleader.com/a-53-increase-in-cannabis-net-revenue-on-aleafia-health-otcmkts-aleafs-q2-2021-financial-results-demonstrates-the-success-of-its-expanded-product-portfolio/
Gaining access to Europe’s legal cannabis market was the most remarkable breakthrough for Aleafia Health (OTCMKTS: ALEAF). It was one of the many activities that contributed to the company’s Q2 2021 financial results.
The most significant shift was a 53% increase of cannabis net revenue from the previous quarter ending at $9.6 million. Increased sales of cannabis across the adult-use, medical and bulk wholesale sales channels played a crucial role in putting together the revenue.
Medical cannabis achieved a $3.3 million net revenue for Q2 2021, a 23% increase over the previous quarter. Adult-use cannabis revenue was at $3.2 million, translating to an 87% increase over the last quarter, while cannabis bulk wholesale sales brought home $3.1 million, compared to $1.9 million previously.
Geeze I hope not! They have the golden goose with the union deal. They just have to onboard the employees and provide them with consistent product. If they need anything it might be more growers but canopy and aurora both suck and have enormous baggage. They would just drag aleafia down. Maybe a deal with a company that knows how to grow consistently good weed….. a thing that eludes both those mentioned so far.
I've wondered about that but if so, why the offering?
Which Canadian LP Will Be The Next Up To Make A Transformative Acquisition?
I think they see the up side here and we are in a very good spot. They awarded warrants (thank you for the correction) so, some dilution but the money comes back to the company and even at a high interest rate it is better than straight dilution. They have a captive audience with the unions and the rest of their operation is gravy.
Those are not shares, they are warrants. At least they have to pay to exercise them.
Let's hope it's a killer deal for them.
Or do you suppose that's what is behind today's PPS rise? Are they trying to drive the PPS up into profit territory for themselves?
The lender accepted a million shares at a value of .32cdn? They see the valueI am getting more as soon as I can
Seems to be quite a wall.
A little surprised Price $0.27 Day's Change 0.04 (17.39%)
Volume(Heavy Day)
Today's volume of 189,226 shares is on pace to be much greater than ALEAF's 10-day average volume of 239,894 shares.
9:57 am ET
They weren't shy about raising it either. Took it down without blinking an eye.
New Money but pummeled, this is all they could raise--->>>Aleafia Health Announces Closing of $10 Million Credit Facility
Canada’s weed sales reach $318M record in June
Nova Scotia’s sales jumped more than any other province
https://mugglehead.com/canadas-weed-sales-reach-318m-record-in-june/
By Kathryn Tindale
Published
2 days ago
Canadians have been out-buying themselves in legal weed this year, with another record set in June for retail cannabis sales.
On Friday, Statistics Canada released preliminary retail sales data, which shows a monthly increase of 1.7 per cent to $318.7 million. This is the fourth consecutive month the country hit record weed sales.
The daily spending average for June is about $10.6 million, and Canada could surpass $3.87 billion in weed sales this year.
Canada’s overall retail sales increased 4.2 per cent in June, primarily led by higher sales at clothing stores. Six provinces saw sales go up, with Ontario and Nova Scotia leading the pack at 9.8 per cent and 16.3 per cent respectively.
Weed sales have also gone up in those two provinces.
Nova Scotia’s sales shot up 10.5 per cent to $8.2 million, the largest jump of any province.
Ontario’s sales rose 8 per cent to $120.1 million, while Ottawa leaped 13.3 per cent to $12.1 million. Toronto’s $43.7 million represents a 5 per cent increase.
Canada’s most populous province has continued to add more retail stores, reaching more than 1,000 as of Friday.
Ontario Cannabis Store
@ONCannabisStore
Aug 20
You can now shop at over 1000 Authorized Cannabis Retailers across Ontario, owned and operated by your local buds. Find a store near you: https://bit.ly/2GZSgh2
https://twitter.com/ONCannabisStore?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E1428778948809342978%7Ctwgr%5E%7Ctwcon%5Es1_&ref_url=https%3A%2F%2Fmugglehead.com%2Fcanadas-weed-sales-reach-318m-record-in-june%2F
Large markets dip while weed sales climb in Maritimes and Prairies
Of the four largest weed markets in Canada, Ontario is the only one to bring in higher sales in June.
Alberta’s sales dropped 4.4 per cent to $57.1 million, and Quebec dipped 0.7 per cent to $49.2 million.
Both provinces had cannabis sales steadily increase for most of the year — with the exception of February — before dipping in June.
Sales had been climbing for three months in British Columbia before dropping 4.1 per cent to $44.5 million in June. Vancouver’s sales decreased by 1.4 per cent to $14.4 million. A total of 371 licences have been issued in B.C. so far.
Saskatchewan sold $13 million, up 0.7 per cent from May, and Manitoba’s sales went up 2 per cent to $12.1 million.
It seems the Maritime provinces are faring better in June than the previous month as well.
In addition to improved sales in Nova Scotia, New Brunswick’s went up 3.4 per cent to $6.6 million. Newfoundland and Labrador saw a similar increase of 3.8 per cent to $4.9 million.
Sales for P.E.I and the Yukon haven’t been provided by StatsCan since March.
There weren’t any June numbers for the Northwest Territories either. Nunavut hasn’t had available sales data and currently only has one store.
Canada retail sales data from May has been revised slightly to $313.18 million.
We are in a very unique and almost secret position here. The industry is forced to stay on the fringes. Away from institutional access. The only ones here with us are the hedge funds who love to play their short games here in otc land. The instant this company shows its value they will turn into longs. Noting has changed in the company’s fundamentals. Their prospects are incredible and nobody seems to understand the situation. I am good with it until I can buy more lol!
Yup, I'm seeing it mac.
And yet we are in low .20’s
I saw that too FUN but it seems since then a dump of the stock. And it continues. Guessing that a split is on the horizon after the dump is complete.
Followers
|
83
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
3373
|
Created
|
12/08/16
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |